How many institutions held SLDB - Solid Biosciences Inc. - Common Stock $0.001 par value per share in Q2 2024?

1 institutional investor reported SLDB - Solid Biosciences Inc. - Common Stock $0.001 par value per share for Q2 2024. Use the holders table for investor-level position and value details.

Solid Biosciences Inc. - Common Stock $0.001 par value per share (SLDB)

Q: What does CUSIP 83422E105 represent in this 13F holders report?

CUSIP 83422E105 is the security identifier for SLDB - Solid Biosciences Inc. - Common Stock $0.001 par value per share used to aggregate holder disclosures.

CUSIP: 83422E105

Q2 2024 13F Holders as of 30 Jun 2024

Security type / class: Equity / Common Stock $0.001 par value per share
Shares outstanding: 100,767,588
Total 13F shares: 7
Share change: +1
Total reported value: $40
Reported price per share: $5.71
Number of holders: 1
Value change: +$6
Number of buys: 1

Security key

83422E105

Report period

Q2 2024

Institutions

Top holders

SLDB full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2024 Previous quarter: Q1 2024 Solid Biosciences Inc. SEC filings Solid Biosciences Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 83422E105

Newer quarter: Q3 2024 Previous quarter: Q1 2024

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top reported holders of SLDB - Solid Biosciences Inc. - Common Stock $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

PERCEPTIVE ADVISORS LLC

13D/G signal

—

Evidence rows

Latest as of

31 Mar 2024

13F Lead comparable stake: 7.4% Showing 1-6 of 15 holder rows.

Rank 1 holder

PERCEPTIVE ADVISORS LLC

13F

Ownership: 7.4%
Position: $92M

13F

Rank 2 holder

RA CAPITAL MANAGEMENT, L.P.

13F

Ownership: 4.7%
Position: $57.68M

13F

Rank 3 holder

Bain Capital Life Sciences Investors, LLC

13F

Ownership: 4.3%
Position: $53.74M

13F

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
PERCEPTIVE ADVISORS LLC	13F Company 13F	7.4%	$91,996,524 6,906,646 shares	—	31 Mar 2024
RA CAPITAL MANAGEMENT, L.P.	13F Company 13F	4.7%	$57,681,541 4,330,446 shares	—	31 Mar 2024
Bain Capital Life Sciences Investors, LLC	13F Company 13F	4.3%	$53,740,632 4,034,582 shares	—	31 Mar 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F Company 13F	2.7%	$33,818,108 2,538,897 shares	—	31 Mar 2024
Artal Group S.A.	13F Company 13F	2.7%	$33,300,000 2,500,000 shares	—	31 Mar 2024
DEERFIELD MANAGEMENT COMPANY, L.P.	13F Company 13F	2.4%	$30,108,501 2,260,398 shares	—	31 Mar 2024

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

Rows available

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

^* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders

Q2 2024 holders

Holder diff

Investor	Q1 2024 Shares	Q2 2024 Shares	Share Diff	Share Chg %	Q1 2024 value	Q2 2024 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend